Abstract
2.23 Efficacy and Safety of Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH) in Children With ADHD: Results From a Pivotal Phase 3 Classroom Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have